Business Alignment PCL
SET:BIZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.2), the stock would be worth ฿3.51 (25% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | ฿4.66 |
0%
|
| 3-Year Average | 1.2 | ฿3.51 |
-25%
|
| 5-Year Average | 1.2 | ฿3.54 |
-24%
|
| Industry Average | 2 | ฿5.76 |
+24%
|
| Country Average | 1.8 | ฿5.36 |
+15%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
B
|
Business Alignment PCL
SET:BIZ
|
2.8B THB | 1.6 | 12.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 0.3 | 23.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 0.2 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.2B USD | 0.2 | 36.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.2B USD | 0.2 | 28.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 2.9 | 34.9 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.6B CNY | 0.3 | 10.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.9 | 22.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
61.7B CNY | 1.8 | 21.8 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
60B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 1.8 |
| 70th Percentile | 3.1 |
| Max | 309.3 |
Other Multiples
Business Alignment PCL
Glance View
Business Alignment Public Co. Ltd. engages in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2016-07-28. The firm is engaged in sales of medical equipment including installation and related activities, such as the construction of building for locating medical equipment, repair and maintenance, and increasing the efficiency of medical equipment. The firm operates through two segments: Sales of medical equipment and Hospital operations. The Sales of medical equipment segment includes installation and related activities such as the construction of building for locating medical equipment, repair and maintenance, and increasing efficiency of medical equipment. The Hospital operations segment is specialized in cancer treatment. The firm is a distributor of radiotherapy products and brachytherapy products (including licensed software) in Thailand and Cambodia.
